PT1007685E - Proteinas expostas na superficie da chlamydia pneumoniae - Google Patents

Proteinas expostas na superficie da chlamydia pneumoniae

Info

Publication number
PT1007685E
PT1007685E PT98928179T PT98928179T PT1007685E PT 1007685 E PT1007685 E PT 1007685E PT 98928179 T PT98928179 T PT 98928179T PT 98928179 T PT98928179 T PT 98928179T PT 1007685 E PT1007685 E PT 1007685E
Authority
PT
Portugal
Prior art keywords
kda
proteins
chlamydia pneumoniae
pneumoniae
relates
Prior art date
Application number
PT98928179T
Other languages
English (en)
Inventor
Svend Birkelund
Gunna Christiansen
Katrine Knudsen
Anna-Sofie Hebsgaard Pedersen
Per Mygind
Original Assignee
Loke Diagnostics Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loke Diagnostics Aps filed Critical Loke Diagnostics Aps
Publication of PT1007685E publication Critical patent/PT1007685E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/125—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT98928179T 1997-06-23 1998-06-19 Proteinas expostas na superficie da chlamydia pneumoniae PT1007685E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK74497 1997-06-23

Publications (1)

Publication Number Publication Date
PT1007685E true PT1007685E (pt) 2006-08-31

Family

ID=8097044

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98928179T PT1007685E (pt) 1997-06-23 1998-06-19 Proteinas expostas na superficie da chlamydia pneumoniae

Country Status (13)

Country Link
US (2) US7264941B1 (pt)
EP (1) EP1007685B1 (pt)
JP (1) JP4160640B2 (pt)
CN (1) CN1249233C (pt)
AT (1) ATE323164T1 (pt)
AU (1) AU749382B2 (pt)
BR (1) BR9810288A (pt)
CA (1) CA2294651A1 (pt)
DE (1) DE69834194T2 (pt)
DK (1) DK1007685T3 (pt)
ES (1) ES2264810T3 (pt)
PT (1) PT1007685E (pt)
WO (1) WO1998058953A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6710033B1 (en) 1996-08-14 2004-03-23 Vanderbilt University Methods and treatment of multiple sclerosis
US6890526B2 (en) 1997-05-06 2005-05-10 Vanderbilt University Methods and reagents for the treatment of multiple sclerosis
US6649370B1 (en) * 1998-10-28 2003-11-18 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
EP1129202A2 (en) * 1998-10-28 2001-09-05 Aventis Pasteur Limited Chlamydia antigenes and corresponding dna fragments and uses thereof
US6872814B2 (en) * 1998-10-29 2005-03-29 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3790900A (en) * 1998-12-01 2000-06-19 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
NZ512308A (en) * 1998-12-01 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
AU775695B2 (en) 1999-03-12 2004-08-12 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof
CA2373021A1 (en) * 1999-05-03 2000-11-09 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
JP4667694B2 (ja) * 1999-09-20 2011-04-13 サノフィ、パストゥール、リミテッド クラミジア抗原および対応するｄｎａ断片ならびにその使用
US20010048927A1 (en) 2000-02-01 2001-12-06 Richard Stephens Porin B (PorB) as a therapeutic target for prevention and treatment of infection by chlamydia
EP1297005B1 (en) * 2000-07-03 2009-08-26 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia pneumoniae
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
US11091792B2 (en) * 2016-05-04 2021-08-17 Children's Hospital & Research Center At Oakland Rapid extraction of nucleic acids from clinical samples for downstream applications
JP2022532050A (ja) * 2019-05-06 2022-07-13 アロセル エービー 呼吸器感染の検出および分類

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU692889B2 (en) * 1994-08-03 1998-06-18 Hitachi Chemical Company, Ltd. Monoclonal antibodies having a reactivity specific to Chlamydia pneumoniae, method for production of the monoclonal antibodies, such antibody producing cells, method for production of the cells, method for detection and/or measurement of Chlamydia pneumoniae, reagents for the method, method and agents for diagnosis of chlamydia pneumoniae infection
ES2321346T3 (es) 1994-09-20 2009-06-04 Hitachi Chemical Co., Ltd. Polinucleotidos que codifican un polipeptido antigenico de chlamydia pneumoniae.
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
CA2294651A1 (en) 1998-12-30
JP4160640B2 (ja) 2008-10-01
DK1007685T3 (da) 2006-08-14
EP1007685B1 (en) 2006-04-12
ATE323164T1 (de) 2006-04-15
US7264941B1 (en) 2007-09-04
DE69834194T2 (de) 2007-03-29
EP1007685A2 (en) 2000-06-14
WO1998058953A2 (en) 1998-12-30
ES2264810T3 (es) 2007-01-16
US20080226679A1 (en) 2008-09-18
WO1998058953A3 (en) 1999-03-18
CN1249233C (zh) 2006-04-05
CN1261403A (zh) 2000-07-26
AU749382B2 (en) 2002-06-27
AU8011998A (en) 1999-01-04
DE69834194D1 (de) 2006-05-24
BR9810288A (pt) 2000-09-19
JP2002510970A (ja) 2002-04-09

Similar Documents

Publication Publication Date Title
PT1007685E (pt) Proteinas expostas na superficie da chlamydia pneumoniae
RU2339646C2 (ru) Гибридная и тандемная экспрессия белков нейссерий
FI953658A0 (fi) Stabiileja bakterisidisia/läpäisevyyttä parantavia proteiinituotteita ja näitä sisältäviä farmaseuttisia koostumuksia
BR9812525A (pt) Proteinase degradadora de complemento humano c3 de streptococcus pneumoniae
WO2002090502A3 (en) Highly conserved proteins from gram-positive bacteria
FR2828405B1 (fr) Vaccin anti-coronavirus
DK1075523T3 (da) Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf
DE60126602D1 (de) Neue collectine
EE200000478A (et) Peptiid, seda kodeeriv geen, diagnostiline reagent ja diagnostiline reaktiivikomplekt ning vaktsiinkasutamiseks riketsioosi ravis
DE60138621D1 (de) Neuartige glykosyltransferase-gene
MX9805158A (es) Adn que codifica una proteina activadora de plasminogeno.
WO2003064446A3 (en) Plasma protein-binding peptides from bacterial curli
WO2004053117A3 (en) Serine protease
WO2002033058A3 (en) Novel cysteine proteases and uses thereof
WO2002050116A3 (en) Adhesion molecule protein
BR0107799A (pt) Proteìna de interação de wt1 wtip
WO2002008393A3 (en) Serine protease from yersinia enterocolitica
WO2002046380A3 (en) Protein kinase
WO2002034901A8 (en) Protein kinase
WO2002062845A3 (en) Adhesion molecules
ATE286535T1 (de) Regulatorisches protein pke 83 aus humanen keratinozyten
TH57274B (th) การก่อภูมิคุ้มกันของวัวนมด้วยโปรตีน GapC ต่อต้านการติดเชื้อ สเทรปโทคอกคัส
TH78124B (th) วัคซีนหน่วยย่อย ns1 ของเฟลวิไวรัส
WO2002062976A3 (en) Serine proteases